Trial Profile
A crossover, open-label, prospective, randomised study evaluating the relative bioavailability of the tablet formulation versus the initial capsule formulation and the effect of food and omeprazole on the pharmacokinetics of a single-dose momelotinib tablet in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Oct 2017
Price :
$35
*
At a glance
- Drugs Momelotinib (Primary) ; Momelotinib; Omeprazole
- Indications Myelofibrosis
- Focus Pharmacokinetics
- 30 Oct 2017 New trial record